1. India Stocks

  2. •

    Health services

  3. •

    Hospital/Nursing management
Narayana Hrudayalaya Ltd.

Narayana Hrudayalaya Ltd.

1,693.20
INR
-31.80
(-1.84%)
40.45EPS
49.07P/E
400.45BMarket Cap
Nov 11Next Earn
Narayana Hrudayalaya Ltd.
NSE:NH
(National Stock Exchange of India)

Recent

price

1,693.20

P/E

ratio

49.07

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
INR
23.36
32.17
41.04
53.55
71.34
79.98
91.33
111.3
139.82
153.08
126.29
179.57
221.16
240.06
269.01
386.92
446.68
Revenue per Share
0.67
1.26
1.21
1.55
-0.88
1.06
4.1
2.53
2.92
5.86
-0.7
16.85
29.85
38.86
38.9
39.67
40.18
Basic EPS, GAAP
-3.76
-2.05
-4.18
-0.93
-1.12
4.17
4.17
-1.06
6.34
16.14
11.54
11.55
27.7
4.73
-4.74
36.73
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
2.41
- -
- -
1
2.5
4
4.48
- -
Dividend per Share
23.53
25.22
26.77
28.4
37.88
42.86
47.13
50.68
52.9
55.59
54.82
72.84
104.3
141.98
178.55
223.4
- -
Book Value per Share
23.36
24.86
26.41
28.01
34.84
39.84
44.15
43.61
45.77
48.75
48.76
67.32
90.29
129.53
166.52
102.84
- -
Tangible Book Value per Share
204
204
204
204
191
200
202
203
203
203
203
203
203
203
203
203
203
Basic Weighted Avg Shares
4,775
6,574
8,386
10,943
13,619
16,031
18,482
22,546
28,357
31,060
25,626
36,445
44,911
48,757
54,637
78,583
90,724
Sales/Revenue/Turnover
5.22
7.06
4.45
7.22
5.71
7.45
9.5
5.75
5.95
8.26
0.89
13.85
17.59
19.23
18.82
15.46
13.56
Operating Margin (%)
321
372
460
574
684
761
799
1,000
1,374
1,858
1,835
1,835
2,100
2,421
2,797
4,495
5,196
Depreciation Expense
136
258
248
317
-168
212
831
513
592
1,189
-143
3,419
6,062
7,893
7,902
8,056
8,161
Net Income, GAAP
34.5
33.46
29.48
37.66
71.13
59.14
38.69
36.04
36.53
26.19
- -
20.4
19.29
11.09
15.58
16.35
17.7
Effective Tax Rate (%)
2.86
3.92
2.96
2.9
-1.23
1.32
4.49
2.28
2.09
3.83
-0.56
9.38
13.5
16.19
14.46
10.25
9
Profit Margin (%)
-46
21
-212
-730
-830
-429
-210
-311
170
-155
-381
1,288
3,067
8,357
13,567
21,049
- -
Working Capital
900
1,157
1,873
2,272
2,066
1,876
1,798
6,963
7,253
8,196
6,735
5,671
7,150
13,446
21,406
55,168
- -
LT Debt
4,809
5,171
5,520
5,832
7,749
8,763
9,633
10,360
10,815
11,365
11,208
14,894
21,324
28,851
36,282
45,395
- -
Total Equity
- -
4.98
4.9
6.04
1.64
3.52
8.45
5.41
5.6
9.08
- -
19.79
24.8
22.32
16.35
11.8
- -
Return on Invested Capital (%)
- -
5.13
5.07
5.95
-0.38
2.9
8.3
5.26
5.59
9.11
- -
18.94
25.31
23.25
17.28
12.27
- -
Return on Capital (%)
- -
5.17
4.67
5.62
-2.48
2.57
9.03
5.14
5.59
10.73
-1.27
26.21
33.49
31.48
24.27
19.74
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
3,407
- -
LT Borrowings
- -
46,672
- -
LT Finance Leases
- -
8,496
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
203
203
203
Market Capitalization
384,265
326,036
400,452

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
39,321
- -
Cash, Cash Equivalents & STI
- -
25,334
- -
Accounts Receivable, Net
- -
6,557
- -
Inventories
- -
1,545
- -
Total Current Liabilities
- -
18,273
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
3,407
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
18.78%
32.45%
25.12%
Free Cash Flow
-171.63%
-203.73%
-875.63%
Net Income, GAAP
-212.37%
-476.18%
1.95%
Sales/Revenue/Turnover
18.5%
25.98%
43.83%
Total Cash Common Dividend
- -
- -
12.02%

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
13,063
13,667
13,346
14,754
54,637
2026
15,073
16,438
21,512
25,938
78,583
2027
26,836
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
9.92
9.78
9.5
9.71
38.9
2026
9.68
12.72
6.24
11.02
39.67
2027
10.2
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
4
2026
- -
- -
- -
- -
4.48
2027
- -
- -
- -
- -
- -
Similar Companies
Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP)
Max Healthcare Institute Ltd (NSE:MAXHEALTH)
Fortis Healthcare Ltd. (NSE:FORTIS)
Bangkok Dusit Medical Services Public Co. Ltd. (SET:BDMS)
Yatharth Hospital and Trauma Care Services Limited (NSE:YATHARTH)
HCA Healthcare, Inc. (NYSE:HCA)
Business
Narayana Hrudayalaya Limited operates as a leading healthcare service provider in India and internationally, specializing in multispecialty and super-specialty hospital networks. Its core products and services encompass cardiac surgery and cardiology; diabetes and endocrinology; gastroenterology; nephrology; neurology; orthopedics; oncology; pulmonology; critical care; imaging and diagnostics; and outpatient and inpatient care through its hospital chain. The company manages a comprehensive portfolio of healthcare facilities, including tertiary care hospitals, specialty clinics, diagnostic laboratories, and health insurance products. Narayana Hrudayalaya operates extensively across major Indian cities such as Bangalore, Delhi, Mumbai, Kolkata, Gurugram, and Ahmedabad, and internationally through its Health City Cayman Islands subsidiary. Founded in 2000 and headquartered in Bangalore, the company is recognized for offering affordable yet advanced medical care through a scalable model. In recent developments, Narayana Hrudayalaya has significantly expanded its global footprint with the acquisition of UK-based Practice Plus Group Hospitals for approximately Rs 2200 crore, marking a strategic move into the European healthcare market. Additionally, the company launched innovative health insurance products in 2024, including 'Aditi' and 'Arya,' targeting insurance complexities and immediate coverage needs. It continues expanding its hospital infrastructure in India, with plans for a 1000-bed advanced specialty hospital in Kolkata and new hospital openings scheduled. Narayana Health has also achieved key accreditations like CAP for its laboratory services, underscoring its commitment to quality and international standards. These strategic expansions and product diversifications align with its vision to broaden access to affordable, high-quality healthcare across geographies and customer segments. The company is publicly listed on NSE and BSE and led by Group CEO Emmanuel Rupert as of January 2019.